Reprint

Arteriogenesis

Molecular Regulation, Pathophysiology and Therapeutics II

Edited by
August 2020
176 pages
  • ISBN978-3-03936-435-0 (Hardback)
  • ISBN978-3-03936-436-7 (PDF)

This book is a reprint of the Special Issue Arteriogenesis—Molecular Regulation, Pathophysiology and Therapeutics II that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Cardiovascular occlusive diseases, such as myocardial infarction or stroke, are still the major cause of morbidity and mortality worldwide and are, particularly during the SARS-CoV-2 pandemic, drastically increasing.  Arteriogenesis, which describes the process of natural arterial bypass growth, is a tissue- and life-saving process, which is given to us by mother nature to compensate for the function of a stenosed coronary or peripheral artery non-invasively. Since our first investigations on the mechanisms of collateral artery growth, more than 20 years ago, a lot of progress has been made, which we aim to make accessible in the current book. We present the available animal models and share information on the used state of the art techniques. We describe how fluid shear stress, the trigger for arteriogenesis, is translated into biochemical signal transduction cascades, and we also highlight the functional role of extracellular RNA and Il10. We address the problematic features of arteriogenesis in patients suffering from diabetes mellitus, and provide an overview of currently available or potentially therapeutic approaches to promote arteriogenesis in patients. We focus on the combination of ultrasound and microbubbles, the permanent occlusion of the internal mammary arteries, and simple exercise training. We believe that we have come much closer to achieving our goal of understanding the mechanisms of arteriogenesis, enabling clinicians to promote collateral artery growth in patients and cure vascular occlusive diseases.

Format
  • Hardback
License
© 2020 by the authors; CC BY-NC-ND license
Keywords
arteriogenesis; therapeutic revascularization; ultrasound; microbubbles; biomaterials; drug and gene delivery; circulating miRNA; miR-143-3p; blood flow restriction; peripheral artery disease; arteriogenesis; strength training; arteriogenesis; endothelial cells; smooth muscle cells; diabetes mellitus; Egr-1; streptozotocin; collateral arteries; insulin; collateral circulation; cerebral collaterals; endothelial cells; ischemic stroke; primary cilia; arteriogenesis; angiogenesis; hind limb ischemia; animal model; mouse; human coronary collateral circulation; extracardiac anastomoses; collateral flow index; collateral artery growth in man; permanent internal mammary artery occlusion; arteriogenesis; exercise training; mouse model; femoral artery ligation; running wheel; voluntary training; peripheral artery disease; SHP-2; tyrosine phosphatase; HIF-1; 26S proteasome; hypoxia; vascular remodeling; angiogenesis; arteriogenesis; VEGF; extracellular RNA; shear stress; endothelial activation; mast cell degranulation; macrophages; sterile inflammation; collateral artery growth; TACE; arteriogenesis; collateral artery; macrophages; macrophage polarization; M2 macrophages; IL10; peripheral arterial disease; arteriogenesis; shear stress; flow cytometry; leukocytes; immunohistology; inflammation; collateral artery growth; n/a